drugset / Trial / NCT00854451

Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection

NCT00854451

RandomizedParallel-groupSingle-blindTreatment

Summary

The aims of this study are (1) to evaluate the prevalence rate of PM of CYP2C19 in our country; (2) to evaluate the efficacy of dual therapy with different dose of omeprazole and amoxicillin; (3) to judge the relationship of genotype of CYP2C19 and the eradication rate of dual therapy in the peptic ulcer patients; (4) to try to find out a predictor of success of dual therapy and an optimal dose of dual therapy as first-line and rescue anti-Helicobacter pylori regimen.

Timeline

Start
1996-08
Primary completion
1997-12
Completion
1998-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 250 mg
Comparator Amoxicillin Other / unclassified 500 mg
Comparator Omeprazole Other / unclassified 20 mg